Levorichter 30

Ethinylestradiol and Levonorgestrel, the active ingredients in Levorichter 30, are a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Levorichter 30 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levorichter 30, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual disorders.

- Contraception: prevents pregnancy in women of childbearing potential. - Menstrual cycle regulation: helps achieve more regular menstrual periods. - Acne management: may improve acne associated with hormonal fluctuations.

Levorichter 30 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or vomiting. - Breast tenderness or enlargement. - Headache or migraine. - Irregular vaginal bleeding or spotting. - Mood changes or irritability. - Weight gain or fluid retention.

Serious or Rare Side Effects: - Deep vein thrombosis, pulmonary embolism, or other thromboembolic events. - Severe hypertension or cardiovascular complications. - Liver dysfunction or jaundice. - Allergic reactions such as rash, swelling, or anaphylaxis.

Before prescribing Levorichter 30, clinicians should evaluate patient history and risk factors.

- Contraindications: active thromboembolic disease, known or suspected estrogen‑dependent tumor, or pregnancy. - Smoking: avoid in women over 35 who smoke due to increased cardiovascular risk. - Hypertension: monitor blood pressure regularly. - Liver disease: use with caution in patients with hepatic impairment. - Migraine with aura: consider alternative contraception. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture and direct sunlight.

Levorichter 30 can interact with several medicines that affect its efficacy or safety.

Major Interactions (Avoid): - Anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Rifampicin or other potent enzyme inducers: can markedly lower hormone levels. - Certain antiretrovirals (e.g., efavirenz): may compromise contraceptive reliability.

Moderate Interactions (Monitor Closely):\n- Antibiotics (e.g., tetracycline, metronidazole): may slightly decrease hormone levels. - Herbal supplements containing St. John's wort: potential reduction in efficacy. - Antifungal agents (e.g., fluconazole): may increase hormone concentrations, requiring monitoring.